Acute myeloblastic leukemia.
Carmen Avellaneda Molina1, Maria José Requena Rodríguez, Nieves Somolinos de Marcos
1Department of Hematology, Hospital Universitario San Agustín, Linares, Jaén, Spain.
Advances in Therapy
|March 25, 2011
Summary
Myelodysplastic syndromes (MDS) transforming to acute myeloblastic leukemia (AML) can be treated with azacitidine. This study presents three cases showing azacitidine
Area of Science:
- Hematology
- Oncology
- Pharmacology
Background:
- Myelodysplastic syndromes (MDS) are clonal hematopoietic stem cell disorders.
- MDS can progress to acute myeloblastic leukemia (AML), a severe malignancy.
- Ineffective hematopoiesis and maturation defects characterize MDS.
Observation:
- Azacitidine is a hypomethylating agent used for MDS and AML treatment.
- Three patient cases illustrate azacitidine's effects in MDS transforming to AML.
- The cases highlight the drug's antitumor activity and toxicity spectrum.
Findings:
- Azacitidine demonstrated varied antitumor responses in patients with MDS-transformed AML.
- Toxicity profiles were observed, necessitating careful patient management.
- The study showcases real-world application of azacitidine in complex hematologic malignancies.
Implications:
- Understanding azacitidine's efficacy and toxicity is crucial for treatment decisions.
- These cases provide insights into managing patients with MDS progressing to AML.
- Further research may optimize azacitidine therapy for improved patient outcomes.
Related Concept Videos
01:27Disorders of Leukocytes
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
01:22Bone Marrow Sampling and Transplants
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...